DeepChek® Assay PROTEASE / REVERSE TRANSCRIPTASE Genotyping and Drug Resistance
Introduction
The DeepChek® Assay -HIV Assay Protease / Reverse Transcriptase Genotyping and Drug Resistance is intended to be used for HIV-1 genotyping and provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). It combines target-specific PCR reagents with in vitro diagnostic software both compatible with either Sanger or Next Generation Sequencing platforms.
Examples of Reports
For NGS Sequencing (DeepChek®-HIV CE-IVD)
For SANGER Sequencing (Viroscore® CE-IVD)
Ordering Information
| Product | Reference |
|---|---|
|
DeepChek® Assay PROTEASE / REVERSE TRANSCRIPTASE Genotyping and Drug Resistance (CE-IVD) |
121A24 |
|
DeepChek® Assay PROTEASE / REVERSE TRANSCRIPTASE Genotyping and Drug Resistance (RUO) |
101B24 |
|
DeepChek® HIV Software (CE-IVD) |
S-12-023 (HL) |
|
ViroScore-HIV Annual Software License (CE-IVD) |
S-09-014 |